查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1526233

連續性腎臟替代療法（CRRT）的全球市場

Continuous Renal Replacement Therapy (CRRT)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 216 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球連續腎臟替代療法 (CRRT) 市場將達到 23 億美元

持續性腎臟替代療法（CRRT）的全球市場預計到 2023 年將達到 15 億美元，預計在 2023 年至 2030 年分析期間將以 5.9% 的複合年成長率成長，並在 2030 年達到 23 億美元。透析和交換液是本報告分析的細分市場之一，預計複合年成長率為 5.4%，到分析期結束時將達到 15 億美元。在分析期間，CRRT拋棄式和系統產業的複合年成長率預計為 6.9%。

美國市場預估為3.705億美元，中國預期複合年成長率為8.3%

預計 2023 年美國連續性腎臟替代療法 (CRRT) 市場規模將達到 3.705 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達3.166億美元，2023年至2030年複合年成長率為8.3%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 3.5% 和 4.7%。在歐洲，德國的複合年成長率預計為 3.8%。

全球連續性腎臟替代療法 (CRRT) 市場 - 主要趨勢和促進因素總結

連續性腎臟替代療法 (CRRT) 是一種透析形式，主要用於加護病房(ICU)，用於治療患有腎衰竭的急性患者，尤其是血流動力學不穩定的患者。與間歇性血液透析機（在數小時內快速去除溶質和水）不同，CRRT 每天進行 24 小時以上，並且更接近模仿腎臟的自然功能。這種溫和、連續的過程透過逐漸清除廢物和多餘的液體，有助於穩定液體狀態波動和腎功能受損的患者。 CRRT 在控制液體超負荷、維持穩定的血流動力學和控制血液化學方面特別有益，這對於無法耐受傳統透析相關快速變化的重症患者至關重要。

CRRT 背後的技術取得了顯著進步，旨在提高安全性、效率以及與其他 ICU 療法的整合。現代 CRRT 設備具有精確的液體平衡控制、複雜的使用者介面和整合的安全功能，有助於預防凝血和低血壓等併發症。這些改進不僅導致 CRRT 在世界各地的 ICU 中引入，而且還將其應用範圍不僅擴展到腎功能支持，還擴展到敗血症和多重器官衰竭的血液淨化技術。此外，正在進行的膜技術和透析液創新旨在提高溶質去除效率，同時最大限度地降低電解質失衡和其他副作用的風險。 CRRT 與 ICU 中其他監測和治療設備的整合代表了一種全面的重症加護方法，並支援管理複雜病例的多方面策略。

持續性腎臟替代治療市場的成長受到多種因素的推動，例如急性腎損傷（AKI）發病率的增加、CRRT 技術的進步、對該療法益處的認知不斷提高以及由此帶來的全球醫療基礎設施的擴大。人口老化以及糖尿病、高血壓和慢性腎臟病等疾病盛行率的上升導致 AKI 發病率上升，刺激了 CRRT 的需求。提高 CRRT 設備效率和安全性的技術進步使這種治療方法更容易獲得和有效，從而鼓勵醫院廣泛採用。此外，隨著醫療保健提供者越來越意識到管理重症患者的細微差別，他們強調 CRRT 相對於傳統腎臟替代療法的好處，這支持了市場的成長。最後，擴大醫療基礎設施，特別是在新興國家，為採用 CRRT 等先進治療方法提供了更多機會，支持整體市場成長。

受訪企業範例（18家知名企業）

  • Toray Industries, Inc.
  • B. Braun Melsungen AG
  • Medtronic PLC
  • Baxter International, Inc.
  • B. Braun Medical, Inc.
  • Fresenius SE & Co. KGaA
  • Nikkiso Co., Ltd.
  • Fresenius Medical Care AG & Co. KgaA
  • Asahi Kasei Medical Co., Ltd.
  • Medica SpA
  • NxStage Medical, Inc.
  • Nipro India Corporation Pvt., Ltd.
  • Xenios AG
  • Infomed SA

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 比賽

簡介目錄
Product Code: MCP11315

Global Continuous Renal Replacement Therapy (CRRT) Market to Reach US$2.3 Billion by 2030

The global market for Continuous Renal Replacement Therapy (CRRT) estimated at US$1.5 Billion in the year 2023, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Dialysates & Replacement Fluids, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the CRRT Disposables & Systems segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$370.5 Million While China is Forecast to Grow at 8.3% CAGR

The Continuous Renal Replacement Therapy (CRRT) market in the U.S. is estimated at US$370.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$316.6 Million by the year 2030 trailing a CAGR of 8.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Continuous Renal Replacement Therapy (CRRT) Market - Key Trends & Drivers Summarized

Continuous Renal Replacement Therapy (CRRT) is a form of dialysis used primarily in the intensive care unit (ICU) to treat acutely ill patients with renal failure, particularly when they are hemodynamically unstable. Unlike intermittent hemodialysis that rapidly removes solutes and fluids over a few hours, CRRT is performed over 24 hours a day, mimicking the kidneys’ natural functions more closely. This gentle and continuous process helps to stabilize patients with fluctuating fluid status and compromised kidney function by allowing for the gradual removal of waste products and excess fluid. CRRT is especially beneficial in managing fluid overload, maintaining stable hemodynamics, and controlling blood chemistry, which is crucial in critically ill patients who may not tolerate the rapid changes associated with conventional dialysis.

The technology behind CRRT has seen significant advancements aimed at enhancing safety, efficiency, and integration with other ICU therapies. Modern CRRT machines offer precise fluid balance control, sophisticated user interfaces, and integrated safety features that help prevent complications such as blood clotting and hypotension. These improvements have not only increased the adoption of CRRT in ICUs around the world but also expanded its applications beyond renal support to include blood purification techniques in sepsis and multi-organ failure. Moreover, ongoing innovations in membrane technology and dialysis solutions are designed to enhance solute removal efficiency while minimizing the risk of electrolyte imbalances and other side effects. The integration of CRRT with other monitoring and therapeutic devices in the ICU represents a comprehensive approach to critical care, supporting a multifaceted strategy for managing complex cases.

The growth in the Continuous Renal Replacement Therapy market is driven by several factors, including an increase in the incidence of acute kidney injury (AKI), advancements in CRRT technology, rising awareness of the therapy’s benefits, and expanding healthcare infrastructure globally. The aging population and higher prevalence of conditions such as diabetes, hypertension, and chronic kidney disease contribute to the rising incidence of AKI, thereby fueling the demand for CRRT. Technological advancements that enhance the efficiency and safety of CRRT machines make this treatment more accessible and effective, encouraging broader adoption across hospitals. Furthermore, as healthcare providers become more aware of the nuances of managing critically ill patients, there is a greater emphasis on the benefits of CRRT over traditional renal replacement therapies, which supports market growth. Lastly, the expansion of healthcare infrastructure, especially in emerging economies, provides additional opportunities for the adoption of advanced medical treatments like CRRT, supporting the overall growth of the market.

Select Competitors (Total 18 Featured) -

  • Toray Industries, Inc.
  • B. Braun Melsungen AG
  • Medtronic PLC
  • Baxter International, Inc.
  • B. Braun Medical, Inc.
  • Fresenius SE & Co. KGaA
  • Nikkiso Co., Ltd.
  • Fresenius Medical Care AG & Co. KgaA
  • Asahi Kasei Medical Co., Ltd.
  • Medica SpA
  • NxStage Medical, Inc.
  • Nipro India Corporation Pvt., Ltd.
  • Xenios AG
  • Infomed SA

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Continuous Renal Replacement Therapy Market Set for a Steady Growth
    • Dialysates & Replacement Fluids Dominate the Market, Disposables to Register the Fastest Growth
    • Continuous Venovenous Hemofiltration (CVVH) Leads the Market, CVVHDF to Exhibit the Fastest Growth
    • Europe and US Hold the Largest Share, China to Witness Fastest Growth
    • Continuous Renal Replacement Therapy (CRRT) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Future Endeavors in CRRT
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increase in Incidence of Acute Kidney Injury to Drive Market Growth
    • Rise in Aging Population, Growing Number of ICU Patients Spurs the Need for CRRT
    • Rising Incidence of Diabetes: A Key Risk Factor for Acute Kidney Failure
    • TABLE 11: Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
    • Increasing Incidence of Cardiovascular Disease Drive Market Growth
    • Prevalence of Heart Failure in Select Countries
    • Advancements in CRRT Machines: Designed for Reliable and Safe Treatment
    • Technological Advancements to Bolster Market Growth
    • Development of CRRT System for Pediatric Patients
    • Miniaturization and Wearable Technology Forays into Acute Renal Replacement Domain
    • Reimbursement Scenario
    • Development of New Hemofilters to Propel Market Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Dialysates & Replacement Fluids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Dialysates & Replacement Fluids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Dialysates & Replacement Fluids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Disposables & Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Disposables & Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Disposables & Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Continuous Venovenous Hemofiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Continuous Venovenous Hemofiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Continuous Venovenous Hemofiltration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Continuous Venovenous Hemodialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Continuous Venovenous Hemodialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Continuous Venovenous Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Continuous Venovenous Hemodiafiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Continuous Venovenous Hemodiafiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Continuous Venovenous Hemodiafiltration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Slow Continuous Filtration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Slow Continuous Filtration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Slow Continuous Filtration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Continuous Renal Replacement Therapy (CRRT) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • JAPAN
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • CHINA
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • EUROPE
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • FRANCE
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • GERMANY
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030

IV. COMPETITION